Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Tenax Therapeutics (TENX) Return on Capital Employed (2016 - 2026)

Tenax Therapeutics' Return on Capital Employed history spans 5 years, with the latest figure at 97.54% for Q4 2017.

  • On a quarterly basis, Return on Capital Employed rose 8380.0% to 97.54% in Q4 2017 year-over-year; TTM through Dec 2017 was 97.54%, a 8380.0% increase, with the full-year FY2017 number at 58.99%, up 6648.0% from a year prior.
  • Return on Capital Employed hit 97.54% in Q4 2017 for Tenax Therapeutics, up from 524.3% in the prior quarter.
  • Over the last five years, Return on Capital Employed for TENX hit a ceiling of 12.24% in Q3 2016 and a floor of 524.3% in Q3 2017.
  • Historically, Return on Capital Employed has averaged 304.11% across 3 years, with a median of 369.39% in 2017.
  • Biggest five-year swings in Return on Capital Employed: plummeted -106249bps in 2013 and later soared 8380bps in 2017.
  • Tracing TENX's Return on Capital Employed over 3 years: stood at 431.64% in 2013, then soared by 58bps to 181.34% in 2016, then surged by 46bps to 97.54% in 2017.
  • Business Quant data shows Return on Capital Employed for TENX at 97.54% in Q4 2017, 524.3% in Q3 2017, and 400.28% in Q2 2017.